Isotretinoin and fenofibrate induce adiposity with distinct effect
4.6 (446) · € 28.50 · Auf Lager
1208_article_07
PDF) Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome
Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension - Kirsty M. Mair, Rosemary Gaw, Margaret R. MacLean, 2020
Pharmacogenetic model of retinoic acid-induced dyslipidemia and insulin resistance
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases
Contribution of Hepatic Retinaldehyde Dehydrogenase Induction to Impairment of Glucose Metabolism by High‐Fat‐Diet Feeding in C57BL/6J Mice - Xu - 2018 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Impact of fenofibrate on NAFLD/NASH: A genetic perspective - ScienceDirect
1208_article_07
Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment - Endotext - NCBI Bookshelf
Frontiers The Regulation of Adipose Tissue Health by Estrogens
Frontiers Single-Gene Congenic Strain Reveals the Effect of Zbtb16 on Dexamethasone-Induced Insulin Resistance
Contribution of Hepatic Retinaldehyde Dehydrogenase Induction to Impairment of Glucose Metabolism by High‐Fat‐Diet Feeding in C57BL/6J Mice - Xu - 2018 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats, BMC Endocrine Disorders
Management of hypertriglyceridemia
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury - ScienceDirect
